Larvol Delta - Asceneuron-Publishes-Pioneering-Preclinical-Efcacy-Data-on-its-Novel-Clinical-Molecule-ASN90-in-Both-Alzheimer39s-and-Parkinson39s-Disease-Models

ASN90 - Asceneuron

https://www.prnewswire.com/news-releases/asceneuron-publishes-pioneering-preclinical-efficacy-data-on-its-novel-clinical-molecule-asn90-in-both-alzheimers-and-parkinsons-disease-models-301515705.html

Apr 1, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next